HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Symrise

This article was originally published in The Rose Sheet

Executive Summary

Firm plans to unveil an anti-aging complex shown to increase endogenous glycosaminoglycans and endogenous collagen by up to 250% and 80%, respectively, at the in-cosmetics 2009 exhibition in Munich, Germany April 21-April 23. A natural cooling agent also will be on display, as well as "a revolutionary ingredient that protects the skin from long-term damage caused by environmental factors, particularly UVB rays," and a "highly efficient aid in line with the trend towards alternative preservative systems," Symrise says. Separately, the fourth-largest flavors and fragrances manufacturer says it has opened an office in Dubai with 15 employees who will oversee local and regional sales and marketing. The new facilities also include two applications laboratories, according to the release, "where flavorings and formulations will be adapted to local taste preferences." Site Manager Torsten Wiltosch states: "Over the past few years, we've established a large number of new contacts and clients in the Arab world. And we see a lot of potential for future business in this region, which is why we're investing in close personal contact." In addition to being a prominent center of tourism and major meeting place for the food industry, Dubai offers "outstanding airline connections to the West, to the rest of the Arab world and to Asia," Symrise notes

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016119

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel